本页面由Tiger Trade Technology Pte. Ltd.提供服务

IN8bio, Inc.

1.28
+0.07005.79%
盘前1.24-0.0400-3.13%05:26 EDT
成交量:10.59万
成交额:13.19万
市值:1,260.43万
市盈率:-0.68
高:1.30
开:1.23
低:1.18
收:1.21
52周最高:2.73
52周最低:0.8800
股本:984.71万
流通股本:719.06万
量比:2.26
换手率:1.47%
股息:- -
股息率:- -
每股收益(TTM):-1.8935
每股收益(LYR):-4.4441
净资产收益率:-111.11%
总资产收益率:-58.37%
市净率:0.69
市盈率(LYR):-0.29

数据加载中...

2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

SEC问询函

Form CORRESP - Correspondence
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/13

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/09

重要事件披露

Form 8-K - Current report
2026/01/26

SEC问询函

Form CORRESP - Correspondence
2025/12/19

重要事件披露

Form 8-K - Current report